Cargando…
Systemic application of teriparatide for steroid induced osteonecrosis in a rat model
BACKGROUND: Steroid associated osteonecrosis is difficult to treat. Teriparatide, as the only one bone anabolic drug, has achieved very promising effect in osteoporosis and other bone skeletal diseases. We carried out this animal study to evaluate the effect of subcutaneous injection of teriparatide...
Autores principales: | Dong, Yulei, Li, Yulong, Huang, Cheng, Gao, Kai, Weng, Xisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499203/ https://www.ncbi.nlm.nih.gov/pubmed/26163144 http://dx.doi.org/10.1186/s12891-015-0589-z |
Ejemplares similares
-
MicroRNA-23a-3p inhibitor decreases osteonecrosis incidence in a rat model
por: Dong, Yulei, et al.
Publicado: (2017) -
Preventive effect of teriparatide on medication-related osteonecrosis of the jaw in rats
por: Park, Kyeong-Mee, et al.
Publicado: (2023) -
Steroid-associated osteonecrosis animal model in rats
por: Zheng, Li-Zhen, et al.
Publicado: (2018) -
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Steroid-induced osteonecrosis
por: Motta, Francesca, et al.
Publicado: (2022)